Advanced Search
Contact | Corporate | Help

Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation

Sponsors:
  • Achillion Pharmaceuticals
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
Resistance
  • HIV Infections
Age Groups:
  • Adult
Gender:
Both
Names:
  • Drug: elvucitabine
  • Drug: Lamivudine
Enrollment:
20

Additional information about NCT00312039.


SourceSolution © 2008-2012